[lin_video src=http://eplayer.clipsyndicate.com/embed/player.js?aspect_ratio=16×9&auto_next=1&auto_start=0&div_id=videoplayer-1366758429&height=480&page_count=5&pf_id=9624&show_title=1&va_id=4029389&width=640&windows=2 service=syndicaster width=640 height=480 div_id=videoplayer-1366758429 type=script]BIRMINGHAM, Ala. (WIAT) — Nearly 22,000 women in the United States are diagnosed with ovarian cancer each year. Of those 22,000 women, 15,000 will die from ovarian cancer every year.
In the past, cancer treatment has been a “one-size-fits-all” approach.
Dr. Laura Shawver, a researcher and ovarian cancer survivor, says when cancer recurs the treatment choices are not clear.
That caused Shawver to start the Clearity Foundation.
The foundation performs molecular profiling.
Tumors are sent to labs and analyzed, and patients are then provided treatment suggestions based on their tumor’s specific genetic makeup.
“We’re doing something that I feel the medical community and the insurance community should already be doing,” Dr. Shawver said.
The Clearity Foundation has profiled the tumors of almost 300 women.
The profiling process can cost anywhere from $500 to $5,000.
Insurance often covers the expense.
Copyright 2013 WIAT-TV CBS 42